Ceftriaxone Dosing for Urinary Tract Infections

Dosing Recommendations by UTI Type

The European Urology guidelines recommend ceftriaxone administration at a dose of 1-2 g intravenously once daily for treating urinary tract infections, with the higher dose recommended for optimal outcomes in complicated UTIs 1
For uncomplicated pyelonephritis, ceftriaxone can be given as an initial one-time dose followed by oral therapy when treating outpatients, as suggested by the Clinical Infectious Diseases guidelines 2
When used as initial parenteral therapy before switching to oral agents for uncomplicated pyelonephritis, a single dose of 1 g is appropriate, according to the Clinical Infectious Diseases guidelines 2
For complicated UTIs, the European Urology guidelines recommend 1-2 g IV once daily, with the higher dose recommended, and a duration of 7-14 days, with 14 days recommended for men when prostatitis cannot be excluded 1, 3

The European Urology guidelines recommend a treatment duration of typically 7 days total therapy, including IV and oral phases, for uncomplicated pyelonephritis 1
For complicated UTIs, the European Urology guidelines recommend a treatment duration of 7-14 days, with the duration closely related to the treatment of the underlying abnormality 3

When switching from IV ceftriaxone to oral therapy, the European Urology and Clinical Infectious Diseases guidelines recommend ensuring the oral agent is active against the identified pathogen 1, 2
Patients should be afebrile for at least 48 hours before considering a switch to oral therapy, as recommended by the European Urology guidelines 3

For patients with fluoroquinolone resistance >10%, the Clinical Infectious Diseases guidelines recommend an initial dose of ceftriaxone 1 g IV before starting oral therapy 2
For complicated UTIs with systemic symptoms, ceftriaxone can be used as empiric monotherapy or in combination with aminoglycosides, as suggested by the Praxis Medical Insights guidelines, but a non-Praxis source is preferred, however, the European Urology guidelines also support the use of ceftriaxone in combination therapy for complicated UTIs 3

Ceftriaxone is particularly effective against common uropathogens, including E. coli, Klebsiella, and Proteus species, as recommended by the European Urology guidelines 1

The Clinical Infectious Diseases guidelines recommend ensuring urine culture and susceptibility testing are performed before or at initiation of therapy to guide treatment 2
The European Urology guidelines recommend not relying on ceftriaxone alone for suspected or confirmed ESBL-producing organisms or multidrug-resistant pathogens 3
The Clinical Infectious Diseases guidelines recommend considering local resistance patterns when selecting empiric therapy 2
For catheter-associated UTIs, addressing the underlying cause, such as removing or changing the catheter when possible, is essential alongside antimicrobial therapy, as recommended by the European Urology guidelines 3

The European Association of Urology guidelines note that both IV and IM ceftriaxone routes are clinically acceptable, with the choice depending on clinical context, highlighting the clinical equivalence of IM and IV administration in terms of efficacy and safety 4, 5
IM injection avoids the discomfort and complications associated with IV line placement, including infiltration, infection, and nerve compression 6

For uncomplicated pyelonephritis in women, 1 g once daily is appropriate, though 2 g may be preferred based on local resistance patterns 7
Pediatric dosing: 50-75 mg/kg once daily (maximum 2 g) for febrile UTI/pyelonephritis 6

Single-dose initial therapy before transitioning to oral antibiotics can be preferred with IM administration 7
Patients with difficult IV access or those at higher risk for IV line complications may prefer IM administration 6
When fluoroquinolone resistance exceeds 10% in the community, a single IM dose of ceftriaxone 1 g provides excellent initial coverage before oral step-down therapy 7